What are the guidelines for colorectal cancer (CRC) detection in average-risk individuals within the last 5 years?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for Colorectal Cancer Detection Within the Last 5 Years

The American Gastroenterological Association, American College of Physicians, and American Cancer Society recommend that average-risk individuals begin colorectal cancer screening at age 45, with colonoscopy every 10 years or annual Fecal Immunochemical Test (FIT) as the preferred first-tier screening options. 1

Recommended Screening Age and Intervals

Average-Risk Individuals:

  • Starting age: 45 years (qualified recommendation) 2, 1
  • Continue screening through: Age 75 for those in good health with life expectancy >10 years 2, 1
  • Ages 76-85: Individualize decisions based on prior screening history, health status, and patient preferences 2, 1
  • Age >85: Discourage screening (risks outweigh benefits) 2, 1

High-Risk Individuals:

  • Family history of CRC or advanced adenoma in first-degree relative <60 years or 2 first-degree relatives at any age: Begin screening at age 40 or 10 years before youngest affected relative's diagnosis, whichever is earlier; repeat every 5 years 1
  • One first-degree relative diagnosed with CRC before age 45: Begin screening at age 30 1
  • Two affected first-degree relatives before age 50: Begin screening at age 20 1

Recommended Screening Tests and Intervals

Tier 1 (Preferred Options):

  • Colonoscopy: Every 10 years
  • FIT (Fecal Immunochemical Test): Annually

Tier 2 (Alternative Options):

  • FIT-fecal DNA (Cologuard): Every 3 years
  • CT colonography: Every 5 years
  • Flexible sigmoidoscopy: Every 5 years
  • High-sensitivity guaiac-based fecal occult blood test: Annually

Test Performance Comparison

Test Sensitivity for CRC Sensitivity for Advanced Precancerous Lesions Specificity
Cologuard 92.3% 42.4% 86.6%
FIT 73.8% 23.8% 94.9%

Follow-up Recommendations

  • All positive results on non-colonoscopy screening tests must be followed up with timely colonoscopy 2, 1
  • Adenomatous polyps found and removed should be followed up with colonoscopy in 3-5 years, depending on size and number 1
  • Personal history of CRC: Surveillance colonoscopy within 1 year of resection, then every 3-5 years if normal 1

Quality Metrics for Screening

  • Colonoscopy quality metrics: Adenoma detection rate, cecal intubation rates, withdrawal time 1
  • FIT quality metrics: Participation rates, inadequate tests, follow-up colonoscopy completion for positive results 1

Important Considerations and Potential Pitfalls

  • African Americans may need to start screening at age 45, even if general population screening begins at 50 1
  • Avoid screening too frequently as there is no evidence it improves outcomes but increases costs 1
  • Consider patient preferences when selecting screening tests to improve adherence 1
  • Avoid continuing screening beyond appropriate age, particularly after age 75 in individuals with negative prior screening 1
  • Be aware of potential harms:
    • Colonoscopy: Small risk of perforation (0.1-0.2%) and bleeding, particularly after polyp removal 1
    • CT colonography: Radiation exposure 1
    • Stool-based tests: False positives leading to unnecessary follow-up procedures 1

The updated guidelines reflect the concerning trend of increasing CRC incidence among adults younger than 55 years, with a 51% increase from 1994 to 2014 and an 11% increase in mortality from 2005 to 2015 2. This has led to the qualified recommendation to begin screening at age 45 for average-risk individuals, while maintaining the strong recommendation for screening at age 50 and older.

References

Guideline

Colorectal Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.